普洛药业：阿莫西林克拉维酸钾片获药品注册证书

Core Viewpoint - Pro Pharmaceutical (000739) announced that its wholly-owned subsidiary, Zhejiang Pro Pharmaceutical Co., Ltd., received a drug registration certificate from the National Medical Products Administration for Amoxicillin and Clavulanate Potassium Tablets, which are used to treat various infections [1] Group 1 - The drug is indicated for the treatment of upper respiratory tract infections, lower respiratory tract infections, urinary system infections, skin and soft tissue infections, and oral infections [1]